《Science Advances,2月3日,A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood》

  • 来源专题:COVID-19科研动态监测
  • 编译者: zhangmin
  • 发布时间:2021-02-25
  • A diagnostic host response biosignature for COVID-19 from RNA profiling of nasal swabs and blood
    Dianna L. Ng1,2,*, View ORCID ProfileAndrea C. Granados2,3,*, Yale A. Santos2,3,*, View ORCID ProfileVenice Servellita2,3,*, View ORCID ProfileGregory M. Goldgof2,...

    Science Advances  03 Feb 2021:
    Vol. 7, no. 6, eabe5984
    DOI: 10.1126/sciadv.abe5984

    Abstract
    Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), which causes coronavirus disease-19 (COVID-19), has emerged as the cause of a global pandemic. We used RNA sequencing to analyze 286 nasopharyngeal (NP) swab and 53 whole-blood (WB) samples from 333 patients with COVID-19 and controls. Overall, a muted immune response was observed in COVID-19 relative to other infections (influenza, other seasonal coronaviruses, and bacterial sepsis), with paradoxical down-regulation of several key differentially expressed genes. Hospitalized patients and outpatients exhibited up-regulation of interferon-associated pathways, although heightened and more robust inflammatory responses were observed in hospitalized patients with more clinically severe illness. Two-layer machine learning–based host classifiers consisting of complete (>1000 genes), medium (<100), and small (<20) gene biomarker panels identified COVID-19 disease with 85.1–86.5% accuracy when benchmarked using an independent test set. SARS-CoV-2 infection has a distinct biosignature that differs between NP swabs and WB and can be leveraged for COVID-19 diagnosis.

     

  • 原文来源:https://advances.sciencemag.org/content/7/6/eabe5984
相关报告
  • 《Cell Host & Microbe,3月21日,A dynamic immune response shapes COVID-19 progression》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2020-03-30
    • A dynamic immune response shapes COVID-19 progression Eugenia Ziying Ong1,2, Yvonne Fu Zi Chan3 , Wan Ying Leong1,2, Natalie Mei Ying Lee3 , Shirin Kalimuddin2,3, Salahudeen Mohamed Haja Mohideen4 , Kian Sing Chan5 , Anthony Tanoto Tan2 , Antonio Bertoletti2 , Eng Eong Ooi1,2,3, and Jenny Guek Hong Low1,2,3,6. Summary The inflammatory response to SARS-coronavirus-2 (SARS-CoV-2) infection is thought to underpin COVID-19 pathogenesis. We conducted daily transcriptomic profiling of three COVID-19 cases and found that the early immune response in COVID-19 patients is highly dynamic. Patient throat swabs were tested daily for SARS-CoV-2 with the virus persisting for 3-4 weeks in all three patients. Cytokine analyses of whole blood revealed increased cytokine expression in the single more severe case. However, most inflammatory gene expression peaked after respiratory function nadir, except those in the IL1 pathway.
  • 《Science,2月26日,Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity》

    • 来源专题:COVID-19科研动态监测
    • 编译者:zhangmin
    • 发布时间:2021-03-03
    • Afucosylated IgG characterizes enveloped viral responses and correlates with COVID-19 severity Mads Delbo Larsen1,2,*, View ORCID ProfileErik L. de Graaf1,2,*, Myrthe E. Sonneveld1,2,*, View ORCID ProfileH. Rosina Plomp3, Jan Nouta3, View ORCID ProfileWilliann... Science  26 Feb 2021: Vol. 371, Issue 6532, eabc8378 DOI: 10.1126/science.abc8378 Structured Abstract INTRODUCTION Antibody function is often considered static and mostly determined by isotype and subclass. The conserved N-linked glycan at position 297 in the Fc domain of immunoglobulin G (IgG) is essential for an antibody’s effector functions. Moreover, this glycan is highly variable and functionally relevant, especially for the core fucose moiety. IgG lacking core fucosylation (afucosylated IgG) causes increased antibody-dependent cellular cytotoxicity (ADCC) through highly increased IgG-Fc receptor IIIa (FcγRIIIa) affinity. Despite constant levels of total plasma IgG-Fc fucosylation above 90%, specific IgG responses with low core fucosylation have been sporadically reported. These are directed against alloantigens on blood cells and glycoproteins of HIV and dengue virus. In this study, we investigated the induction of afucosylated IgG to various antigens and delineated its dynamics and proinflammatory potential in COVID-19. RATIONALE Afucosylated IgG responses have only been found in various alloimmune responses against cellular blood groups and two enveloped viruses. Therefore, we tested the hypothesis that foreign surface–exposed, membrane-embedded proteins induce a specific B cell response that results in afucosylated IgG. We compared immune responses to natural infections by enveloped viruses and nonenveloped viruses, protein subunit vaccination, and live attenuated virus vaccinations. We also assessed the relation to the clinical outcome of such a response in COVID-19.